Paradigm Biopharmaceuticals Ltd.ASX: PAR

Primary and Secondary endpoints met in MPS I Trial

Jun 6, 2023 at 6:48 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment